CLASS II ONGOING Device recall · Reported 3 Aug 2022 · FDA Enforcement Report

Cobalt Implantable Cardioverter Defibrillators recalled

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) is recalling Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy, distributed nationwide in the US. The recall was initiated on 5 Nov 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN 00763000178178, Serial Numbers: RTK601865S, RTK601825S, RTK601828S
Quantity recalled3 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1480-2022
FDA event ID
90429
Classification
Class II
Status
Ongoing
Recall initiated
5 Nov 2020
FDA classified
28 Jul 2022
Reported
3 Aug 2022
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Potency & Assay

Timeline

5 Nov 2020Recall initiated by company
28 Jul 2022Classified by FDA+630 days
3 Aug 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Manufacturing error that may have resulted in a cathode component being out of specification. All devices met final functional testing requirements.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy (CRT-D)

Where it was distributed

US Nationwide distribution in the states of Indiana and CA.

Nationwide CaliforniaIndiana

Questions about this recall

Is Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy recalled?

Yes. Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) recalled Cobalt Implantable Cardioverter Defibrillators with Cardiac Resynchronization Therapy on 5 Nov 2020. The recall is Class II and its status is Ongoing. Recall number Z-1480-2022.

Why was it recalled?

Manufacturing error that may have resulted in a cathode component being out of specification. All devices met final functional testing requirements.

Which lots are affected?

GTIN 00763000178178, Serial Numbers: RTK601865S, RTK601825S, RTK601828S

Where was it sold?

US Nationwide distribution in the states of Indiana and CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

All 136

Other Pacemakers & Defibrillators recalls

All 493